SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006554
Filing Date
2020-05-14
Accepted
2020-05-14 07:44:59
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20200331x10q.htm 10-Q 1478327
2 EX-31.1 hook-20200331ex3111b5787.htm EX-31.1 12133
3 EX-31.2 hook-20200331ex312319d70.htm EX-31.2 12149
4 EX-32.1 hook-20200331ex321c538c1.htm EX-32.1 12487
  Complete submission text file 0001558370-20-006554.txt   6081582

Data Files

Seq Description Document Type Size
5 EX-101.INS hook-20200331.xml EX-101.INS 1184521
6 EX-101.SCH hook-20200331.xsd EX-101.SCH 57266
7 EX-101.CAL hook-20200331_cal.xml EX-101.CAL 62205
8 EX-101.DEF hook-20200331_def.xml EX-101.DEF 187123
9 EX-101.LAB hook-20200331_lab.xml EX-101.LAB 480748
10 EX-101.PRE hook-20200331_pre.xml EX-101.PRE 358112
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 20875308
SIC: 2834 Pharmaceutical Preparations